Monopar Therapeutics Inc. · NASDAQ:MNPR
Adage Capital Management, L.P. reported a 6.23% stake in Monopar Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 13, 2026
Adage Capital Management, L.P. reported a 6.23% stake in Monopar Therapeutics Inc., 424,195 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G/A).
- Stake
- 6.23%
- Shares
- 424,195
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 6.23% | 424,195 |
| Robert Atchinson | 6.23% | 424,195 |
| Phillip Gross | 6.23% | 424,195 |
Source
Related
- Monopar Therapeutics Inc.
- Adage Capital Management, L.P.
- Monopar Therapeutics Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2025
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026